Virtual reality intervention alleviates dyspnoea in patients recovering from COVID-19 pneumonia.

Sophie BetkaOliver Alan KannapeJemina FasolaFlorian LanceSylvain CardinAline SchmitThomas SimilowskiPaola Marina SoccalBruno Herbelin Dan AdlerOlaf Blanke

Published in: ERJ open research (2023)

Our iVR-based digital therapy presents a feasible and safe respiratory rehabilitation tool that improves breathing comfort in patients recovering from COVID-19 infection presenting with persistent dyspnoea. Future research should investigate the intervention's generalisability to persistent dyspnoea with other aetiologies and its potential for preventing chronification.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
intensive care unit
mouse model
bone marrow
patient reported outcomes
mesenchymal stem cells